Analyst consensus rating
U.S. Physical Therapy Analyst Rating: Buy
USPH is rated Buy by 6 analysts with a $95.00 target. As of 2026-08-18.
Direct answer
U.S. Physical Therapy's consensus rating is Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $95.00.
Forecast evidence checked August 18, 2026.
Get free U.S. Physical Therapy email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $78.21
- Average price target
- $95.00
- High price target
- $100.00
- Low price target
- $88.00
- Low target gap
- +12.5%
- Target upside
- +21.5%
- High target gap
- +27.9%
- Target range width
- 15.3%
- Consensus rating
- Buy
- Analysts
- 6
- Evidence date
- August 18, 2026
- Valid through
- August 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for U.S. Physical Therapy?
U.S. Physical Therapy has a verified Buy consensus. The same dataset has an average price target of $95.00.
How far are U.S. Physical Therapy's low and high targets from the recorded price?
The low target implies +12.5%, while the high target implies +27.9%.
How many analysts are included in U.S. Physical Therapy's consensus?
The verified consensus includes 6 analysts.
How is U.S. Physical Therapy's target upside or downside calculated?
The average target of $95.00 is divided by the recorded price of $78.21, then one is subtracted to produce +21.5%. This does not guarantee a future return.
When was U.S. Physical Therapy's analyst forecast verified?
The data was verified on 2026-08-18. The dataset is valid through 2026-08-25.